These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6242259)
41. Modern management of thalassemia. Festa RS Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631 [No Abstract] [Full Text] [Related]
42. [Thalassemia major: chelating therapy with deferoxamine]. Abreu de Miani MS; Sanchis de Herrlein MS; Peñalver JA Medicina (B Aires); 1985; 45(3):231-4. PubMed ID: 3841934 [No Abstract] [Full Text] [Related]
43. Thalassemia. Poncz M; Cohen A; Schwartz E Adv Pediatr; 1984; 31():43-86. PubMed ID: 6516946 [No Abstract] [Full Text] [Related]
44. [Chelating therapy in beta-thalassemia]. Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040 [TBL] [Abstract][Full Text] [Related]
45. Liver iron overload and liver fibrosis in thalassemia. Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556 [No Abstract] [Full Text] [Related]
46. T2* magnetic resonance and myocardial iron in thalassemia. Pennell DJ Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685 [TBL] [Abstract][Full Text] [Related]
47. [The echocardiographic evaluation of multiply transfused thalassemia patients over the age of 10]. De Martino MP; Multari EI; Costantino D; Mammì F; Iannopollo M; Costantino G Pediatr Med Chir; 1990; 12(4):365-9. PubMed ID: 2075101 [TBL] [Abstract][Full Text] [Related]
48. Ocular findings in beta-thalassemia. Sorcinelli R; Sitzia A; Figus A; Lai ME Metab Pediatr Syst Ophthalmol (1985); 1990; 13(1):23-5. PubMed ID: 2370833 [TBL] [Abstract][Full Text] [Related]
50. Problems related to treatment of beta-thalassaemia major. Economidou J Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374 [TBL] [Abstract][Full Text] [Related]
51. The chronically transfused patient: advances in treatment. McCullough J; Jacob HS Hosp Pract (Off Ed); 1985 Jul; 20(7):77-84. PubMed ID: 3924941 [No Abstract] [Full Text] [Related]
52. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547 [TBL] [Abstract][Full Text] [Related]
53. Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major. Marcus RE; Davies SC; Bantock HM; Underwood SR; Walton S; Huehns ER Lancet; 1984 Feb; 1(8373):392-3. PubMed ID: 6141447 [No Abstract] [Full Text] [Related]
54. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis]. Orsini A; Giraud F; Bernard P; Passeron P Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127 [No Abstract] [Full Text] [Related]
56. [The endocrine complications in thalassemia major]. Anastasi S; Caruso V; Magnano C; Leocata A Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458 [TBL] [Abstract][Full Text] [Related]
57. [Effects of desferrioxamine on iron elimination in children after multiple transfusions]. Leggio ML Minerva Pediatr; 1966 Feb; 18(3):101-3. PubMed ID: 5930397 [No Abstract] [Full Text] [Related]
58. Editorial retrospective. Iron loading in thalassemia--five years with the pump. Weatherall DJ; Pippard MJ; Callender ST N Engl J Med; 1983 Feb; 308(8):456-8. PubMed ID: 6823257 [No Abstract] [Full Text] [Related]
59. Iron chelation. Hershko C; Link G; Pinson A Prog Clin Biol Res; 1989; 309():133-40. PubMed ID: 2675082 [No Abstract] [Full Text] [Related]
60. [Cardiological problems in thalassemia major]. Mancuso L G Ital Cardiol; 1988 Aug; 18(8):665-70. PubMed ID: 3243416 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]